查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561560

2024-2032 年按样本类型、生物样本库类型、应用、最终用户和地区分類的生物样本库市场报告

Biobanking Market Report by Specimen Type, Biobank Type, Application, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球生物银行IMARC Group规模达到610亿美元。基因组研究活动数量的增加、慢性病盛行率的增加以及对虚拟生物库的日益关注是推动市场发展的一些关键因素。

生物样本库是指收集、储存、註释和重新分配体液或组织样本以进行研究的过程，以提高对健康和疾病的了解。它是一个可靠的样本中心，可以存取高品质样本池和相关资料。它对于多种疾病的诊断和药物生产至关重要。它为改进个人化医疗方法提供了基础，其中有效的生物标记识别对于疾病诊断和预后至关重要。它充当众多研究和不同研究的捐助者和研究人员之间的调解人。它具有高品质的控制，有助于提高各种实验的再现性。它还提供透过生物样本产生的资料，这对于卫生系统的数位转型至关重要。因此，生物样本库在全球广泛应用于药物和生物标记开发、临床治疗护理以及监测药物对最终结果影响的临床试验。

生物样本库市场趋势：

目前，由于基因组研究活动数量的增加，对生物样本库的需求不断增长，这是支持市场成长的关键因素之一。除此之外，全球范围内越来越多的生物样本库，由于其具有提高生物医学研究资料的再现性和意义的潜力，正在提供积极的市场前景。此外，世界各地的群众中糖尿病、高血压、癌症、心臟病和呼吸系统疾病等慢性病的盛行率也在上升。再加上对生物样本库开发能够有效识别病原体的诊断方法的需求不断增加，正在推动市场的成长。除此之外，再生医学、个人化医学和癌症基因组研究等先进疗法的支出不断增加，为产业投资者提供了利润丰厚的成长机会。此外，临床实验室对生物样本开发基因检测方法的需求不断增加，对市场产生了积极影响。此外，人们越来越关注虚拟生物库，它可以最大限度地减少时间限制，产生高收入，并允许研究人员顺利进行研究，这也促进了市场的成长。此外，主要参与者正在推出生物样本库软体解决方案，该解决方案有助于提高知名度并提高为客户提供的服务质量，从而加强市场成长。

本报告回答的关键问题

  • 2023 年全球生物样本库市场规模有多大？ 2024-2032年全球生物样本库市场的预期成长率是多少？
  • 推动全球生物样本库市场的关键因素是什么？
  • COVID-19 对全球生物样本库市场有何影响？
  • 根据标本类型，全球生物样本库市场的细分如何？
  • 根据生物样本库类型，全球生物样本库市场的划分是怎么样的？
  • 基于应用的全球生物样本库市场的细分情况如何？
  • 基于最终用户的全球生物样本库市场的划分是怎么样的？
  • 全球生物样本库市场的关键区域有哪些？
  • 谁是全球生物样本库市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球生物样本库市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依样本类型

  • 血液製品
    • 市场趋势
    • 市场预测
  • 固体组织
    • 市场趋势
    • 市场预测
  • 细胞系
    • 市场趋势
    • 市场预测
  • 核酸
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依生物样本库类型

  • 基于人群的生物样本库
    • 市场趋势
    • 市场预测
  • 以疾病为导向的生物样本库
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 疗法
    • 市场趋势
    • 市场预测
  • 研究
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 学术机构
    • 市场趋势
    • 市场预测
  • 製药和生物技术公司
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Brooks Automation Inc.
    • Bay Biosciences LLC
    • Boca Biolistics
    • Ctibiotech
    • Cureline Inc.
    • Firalis
    • Greiner Bio-One International GmbH
    • Hamilton Company
    • Merck KGaA
    • ProteoGenex Inc.
    • Thermo Fisher Scientific Inc.
    • VWR Corporation (Avantor Inc.)
Product Code: SR112024A4967

The global biobanking market size reached US$ 61.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 99.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. The rising number of genomic research activities, increasing prevalence of chronic diseases, and rising focus on virtual biobank represent some of the key factors driving the market.

Biobanking refers to the process wherein samples of bodily fluid or tissue are collected, stored, annotated, and redistributed for research to improve the understanding of health and disease. It is a reliable hub of samples and enables access to a pool of high-quality samples and associated data. It is essential for the diagnosis and production of medicines for numerous disorders. It provides a basis for improving personalized medical approaches wherein effective biomarker identification is vital for disease diagnosis and prognosis. It serves as a mediator between donor and researcher for numerous research and different studies. It has high-quality control and assists in improving the reproducibility of various experiments. It also offers data generated through biosamples that is crucial for the digital transformation of health systems. As a result, biobanking is widely utilized in drug and biomarker development, clinical care for therapy, and clinical trials monitoring for the effects of drugs on eventual outcomes across the globe.

Biobanking Market Trends:

At present, the rising demand for biobanking due to the increasing number of genomic research activities represents one of the key factors supporting the growth of the market. Besides this, the growing number of biobanks across the globe, due to its potential to enhance the reproductivity and meaning of data generated by biomedical research, is offering a positive market outlook. Additionally, there is a rise in the prevalence of chronic diseases, such as diabetes, hypertension, cancer, heart attack, and respiratory disorders, among the masses around the world. This, coupled with the increasing demand for biobanking to develop diagnostics that can effectively identify pathogens, is propelling the growth of the market. Apart from this, the rising expenditure in advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, is offering lucrative growth opportunities to industry investors. Moreover, the increasing demand for biospecimens from clinical labs to develop assays for genetic testing is positively influencing the market. In addition, the growing focus on virtual biobank that minimizes time constraints, generates high revenue, and allows researchers to conduct the research smoothly is contributing to the growth of the market. Furthermore, key players are introducing a biobank software solution that assists in gaining visibility and improving the quality of the service provided to customers, which is strengthening the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biobanking market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on specimen type, biobank type, application and end user.

Specimen Type Insights:

  • Blood Products
  • Solid Tissue
  • Cell Lines
  • Nucleic Acid
  • Others

The report has provided a detailed breakup and analysis of the biobanking market based on the specimen type. This includes blood products, solid tissue, cell lines, nucleic acid, and others. According to the report, blood products represented the largest segment.

Biobank Type Insights:

  • Population-based Biobanks
  • Disease-oriented Biobanks

A detailed breakup and analysis of the biobanking market based on the biobank type has also been provided in the report. This includes population-based biobanks and disease-oriented biobanks. According to the report, disease-oriented biobanks accounted for the largest market share.

Application Insights:

  • Therapeutics
  • Research

A detailed breakup and analysis of the biobanking market based on the application has also been provided in the report. This includes therapeutics and research. According to the report, research accounted for the largest market share.

End-User Insights:

  • Academic Institutions
  • Pharma and Biotech Companies

A detailed breakup and analysis of the biobanking market based on the end-user has also been provided in the report. This includes academic institutions and pharma and biotech companies. According to the report, academic institutions accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe was the largest market for biobanking. Some of the factors driving the Europe biobanking market included rising advancements in the stem cell and regenerative medicine research, increasing awareness about stem cell therapies, high demand for automated alarm monitoring devices, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global biobanking market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc., VWR Corporation (Avantor Inc.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global biobanking market in 2023?
  • 2. What is the expected growth rate of the global biobanking market during 2024-2032?
  • 3. What are the key factors driving the global biobanking market?
  • 4. What has been the impact of COVID-19 on the global biobanking market?
  • 5. What is the breakup of the global biobanking market based on the specimen type?
  • 6. What is the breakup of the global biobanking market based on the biobank type?
  • 7. What is the breakup of the global biobanking market based on the application?
  • 8. What is the breakup of the global biobanking market based on the end user?
  • 9. What are the key regions in the global biobanking market?
  • 10. Who are the key players/companies in the global biobanking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biobanking Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Specimen Type

  • 6.1 Blood Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Solid Tissue
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cell Lines
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Nucleic Acid
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Biobank Type

  • 7.1 Population-based Biobanks
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Disease-oriented Biobanks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Therapeutics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Academic Institutions
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pharma and Biotech Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Brooks Automation Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bay Biosciences LLC
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boca Biolistics
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Ctibiotech
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Cureline Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Firalis
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Greiner Bio-One International GmbH
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Hamilton Company
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Merck KGaA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 ProteoGenex Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 VWR Corporation (Avantor Inc.)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Biobanking Market: Major Drivers and Challenges
  • Figure 2: Global: Biobanking Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biobanking Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Biobanking Market: Breakup by Specimen Type (in %), 2023
  • Figure 5: Global: Biobanking Market: Breakup by Biobank Type (in %), 2023
  • Figure 6: Global: Biobanking Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Biobanking Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Biobanking Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Biobanking (Blood Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Biobanking (Blood Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Biobanking (Solid Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Biobanking (Solid Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Biobanking (Cell Lines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Biobanking (Cell Lines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Biobanking (Nucleic Acid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Biobanking (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Biobanking (Other Specimen Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Biobanking (Other Specimen Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Biobanking (Population-based Biobanks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Biobanking (Population-based Biobanks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Biobanking (Disease-oriented Biobanks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Biobanking (Disease-oriented Biobanks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Biobanking (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Biobanking (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Biobanking (Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Biobanking (Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Biobanking (Academic Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Biobanking (Academic Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Biobanking (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Biobanking (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Biobanking Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Biobanking Industry: SWOT Analysis
  • Figure 81: Global: Biobanking Industry: Value Chain Analysis
  • Figure 82: Global: Biobanking Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biobanking Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biobanking Market Forecast: Breakup by Specimen Type (in Million US$), 2024-2032
  • Table 3: Global: Biobanking Market Forecast: Breakup by Biobank Type (in Million US$), 2024-2032
  • Table 4: Global: Biobanking Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Biobanking Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Biobanking Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Biobanking Market: Competitive Structure
  • Table 8: Global: Biobanking Market: Key Players